Eli Lilly and Company is licensing a technology for implanting pancreatic beta cells in people with type 1 diabetes, from Sigilon Therapeutics Inc., an enterprise making implants of live cells to treat chronic diseases. . . . → Read More: Lilly, Cell Implants Start-Up Partner on Diabetes
|
|||||
       |
An engineering lab demonstrates how polymer gels and ambient sunlight can provide a simple, inexpensive alternative to current complex and expensive technologies for desalinating or purifying drinking water. . . . → Read More: Hydrogel, Solar Power Provide Simple Water Purification  Comments are closed  New products  biomedical, energy, engineering, materials science, nanotechnology, patent, physical sciences, solar, university Today, the most powerful medium for any type of commercial practice is a website; your website must show the problem you solve and why you are relevant to your target audience. . . . → Read More: Packaging Up Your Solution A new enterprise is formed to develop treatments for cancer using donated T-cells from the immune system, rather than the patient’s own T-cells, engineered to attack cancer cells. . . . → Read More: New Company Acquires Off-the-Shelf T-Cell Cancer Therapies One comment - (Comments are closed) Finance, Intellectual property, Joint ventures/collaborations biomedical, biotechnology, cancer, entrepreneurs, equity, genomics, investment, licensing, life sciences, patent, pharmaceuticals, venture capital A bioengineering group created a process for producing a cough suppressant in the lab, usually derived from opium poppies, but instead from genetically modified brewer’s yeast. . . . → Read More: Cough Suppressant Produced from Engineered Yeast Cells Comments are closed Intellectual property, New products biomedical, biotechnology, cancer, engineering, entrepreneurs, genomics, grant, licensing, life sciences, NIH, NSF, patent, pharmaceuticals, university A pharmaceutical researcher developed treatments for chronic pain, formulated as nanoscale droplets, that in tests with lab animals target the source of pain directly and use much smaller doses than current pain drugs. . . . → Read More: Nanotech Pain Drug Formulations Developed One comment - (Comments are closed) New products biomedical, life sciences, manufacturing, materials science, nanotechnology, pharmaceuticals, university MedImmune, the biologics subsidiary of drug maker AstraZeneca, is licensing antibodies from a biotechnology company for treatments that simultaneously address two or more cancer targets. . . . → Read More: Antibodies Licensed for Multi-Target Immunotherapies Comments are closed Intellectual property biomedical, biotechnology, cancer, genomics, Israel, licensing, life sciences, mathematics, pharmaceuticals, physical sciences |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts